Medicare Enrolled
Dr. Mark Miller, M.D.
Optician · Cranford, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Miller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miller?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Miller
Dr. Mark Miller is an optician specialist in Cranford, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Miller performed 14,127 Medicare services across 5,444 unique beneficiaries.
Between the years covered by Open Payments, Dr. Miller received a total of $15,457 from 50 pharmaceutical and/or device companies across 443 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Miller is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in NJ
$15,457 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,127
Medicare services
Top 4% in NJ for optician
5,444
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~706 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, degarelix, 1 mg | 2,880 | $3 | $7 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
2,400 | $5 | $12 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
1,835 | $3 | $11 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,044 | $101 | $274 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
875 | $70 | $188 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
636 | $10 | $116 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
625 | $8 | $15 |
| PSA test (prostate cancer screening) | 591 | $18 | $76 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
511 | $10 | $164 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
443 | $39 | $168 |
| Other procedure on male genital system A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories. |
285 | $79 | $1,441 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
213 | $28 | $121 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 206 | $128 | $413 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
177 | $51 | $201 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
139 | $8 | $33 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
138 | $8 | $34 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
113 | $131 | $412 |
| Complete ultrasound of abdomen A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen. |
87 | $102 | $432 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
87 | $12 | $72 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
85 | $214 | $890 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
80 | $8 | $13 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
79 | $8 | $33 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
70 | $68 | $350 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
65 | $125 | $336 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
47 | $285 | $1,143 |
| Injection, garamycin, gentamicin, up to 80 mg | 47 | $2 | $3 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
42 | $96 | $389 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
36 | $327 | $1,205 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $40 | $116 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
26 | $21 | $59 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
26 | $25 | $106 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
25 | $188 | $1,443 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
24 | $82 | $2,500 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
22 | $342 | $1,764 |
| Bladder/urethra growth removal via endoscope, 0.5-2.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters. |
21 | $194 | $1,905 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $149 | $497 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
17 | $48 | $389 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
17 | $8 | $35 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $158 | $366 |
| Manipulation of stone in ureter using an endoscope | 15 | $219 | $3,305 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
13 | $488 | $5,085 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
12 | $600 | $11,395 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
50.6% medium
49.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,457
Total received (2018-2024)
Avg $2,208/year across 7 years
Top 7% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
443
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,468 (67.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,989 (32.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$900
2023
$594
2022
$758
2021
$1,182
2020
$6,132
2019
$2,794
2018
$3,097
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Antares Pharma, Inc.
$282
Tolmar, Inc.
$159
Myriad Genetic Laboratories, Inc.
$141
Medtronic, Inc.
$66
Janssen Biotech, Inc.
$47
Cook Medical LLC
$44
COLOPLAST CORP
$32
UROGEN PHARMA, INC.
$29
Tempus AI, Inc
$28
Calyxo, Inc.
$23
MIMEDX Group, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$15
ABBVIE INC.
$14
Top 3 companies account for 64.6% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$8,174
Metuchen Pharmaceuticals
$2,557
Myriad Genetic Laboratories, Inc.
$646
Antares Pharma, Inc.
$484
Janssen Biotech, Inc.
$402
Endo Pharmaceuticals Inc.
$400
Bayer HealthCare Pharmaceuticals Inc.
$339
Boston Scientific Corporation
$241
Medtronic, Inc.
$190
Dendreon Pharmaceuticals LLC
$177
Tolmar, Inc.
$176
Myovant Sciences Inc.
$159
PFIZER INC.
$135
180 Medical, Inc.
$103
Acerus Pharmaceuticals Corporation
$92
Axonics, Inc.
$89
Medtronic USA, Inc.
$80
Aytu BioScience, Inc
$76
Allergan Inc.
$74
Allergan, Inc.
$68
Janssen Products, LP
$60
UROGEN PHARMA, INC.
$58
Axonics Modulation Technologies, Inc.
$52
Teleflex LLC
$47
Cook Medical LLC
$44
UROVANT SCIENCES INC
$42
Amgen Inc.
$40
AstraZeneca Pharmaceuticals LP
$38
Bayer Healthcare Pharmaceuticals Inc.
$33
COLOPLAST CORP
$32
Tempus AI, Inc
$28
MEDIVATION FIELD SOLUTIONS LLC
$26
Hollister Incorporated
$26
AbbVie, Inc.
$25
Calyxo, Inc.
$23
MIMEDX Group, Inc.
$22
Janssen Pharmaceuticals, Inc
$20
GENZYME CORPORATION
$17
Mission Pharmacal Company
$15
Progenics Pharmaceuticals, Inc.
$15
Merck Sharp & Dohme LLC
$14
Merck Sharp & Dohme Corporation
$14
MISSION PHARMACAL COMPANY
$14
Novartis Pharmaceuticals Corporation
$14
ABBVIE INC.
$14
AKRIMAX PHARMACEUTICALS, LLC
$14
TOLMAR Pharmaceuticals, Inc.
$13
Palette Life Sciences, Inc.
$13
Aytu Bioscience, Inc
$11
Blue Earth Diagnostics Limited
$11
Top 3 companies account for 73.6% of all-time payments
Associated products mentioned in payments ›
AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · CVAC ASPIRATION SYSTEM · EDEX · ELIGARD · ERLEADA · Erleada · FENSOLVI · GEMTESA · INTERSTIM · Infyna Chic · JELMYTO · KEYTRUDA · LITHO 150 · LYNPARZA · LithoVue · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Nubeqa · ORGOVYX · PLUVICTO · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · SpaceOAR VUE System - 10mL · SpeediCath · Stendra · S~CURVE · TESTOPEL · TOVIAZ · URIBEL · Uribel · UroLift 2 System · UroLift System · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for optician in NJ.
Geographic Context
Opticians within 10 mi
10,964
Per 100K population
1914.9
County median income
$100,117
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
3.7 mi
3.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Miller is a mixed practice specialist, with above-average Medicare volume (top 4% in NJ), with speaking/promotional industry engagement in the top 7% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Miller experienced with injection, degarelix, 1 mg?
Based on Medicare claims data, Dr. Miller performed 2,880 injection, degarelix, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miller receive payments from pharmaceutical companies?
Yes. Dr. Miller received a total of $15,457 from 50 companies across 443 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miller's costs compare to other opticians in Cranford?
Dr. Miller's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Cranford
Browse opticians in Cranford ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NJ
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NJ
Which NJ opticians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Metuchen Pharmaceuticals Payments to Doctors
See all physicians who received payments from Metuchen Pharmaceuticals.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology